Ligand profile
ZINC336013
Virtual-screening candidate from ZINC.
Bound to: VK055_4853 — 2-succinyl-5-enolpyruvyl-6-hydroxy-3- cyclohexene-1-carboxylic-acid synthase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC336013- UniProt (similar protein)
P9WK11- Tanimoto
- 0.571
- Target protein
- VK055_4853
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 83.8
- −1 ≤ LogP ≤ 5 2.17
- MW ≤ 500 Da 246.2
- LogP ≤ 5 2.17
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 83.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)Oc1cc(C(=O)O)c(O)c2ccccc12CC(=O)Oc1cc(C(=O)O)c(O)c2ccccc12
InChI=1S/C13H10O5/c1-7(14)18-11-6-10(13(16)17)12(15)9-5-3-2-4-8(9)11/h2-6,15H,1H3,(H,16,17)InChI=1S/C13H10O5/c1-7(14)18-11-6-10(13(16)17)12(15)9-5-3-2-4-8(9)11/h2-6,15H,1H3,(H,16,17)
NZJOAGSJKPWLBD-UHFFFAOYSA-NNZJOAGSJKPWLBD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- DNA
- Homolog
- P9WK11
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC336013 →
- ZINC ZINC20 ZINC336013 →
- UniProt UniProt P9WK11 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC336013”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4853.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).